OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 40 filers reported holding OVID THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,061 | -68.1% | 6,579 | +26.5% | 0.00% | – |
| Q1 2024 | $15,863 | -5.3% | 5,201 | 0.0% | 0.00% | – |
| Q4 2023 | $16,747 | -5.5% | 5,201 | +12.7% | 0.00% | – |
| Q3 2023 | $17,714 | -6.3% | 4,613 | -20.0% | 0.00% | – |
| Q2 2023 | $18,903 | -10.0% | 5,763 | +10.8% | 0.00% | – |
| Q1 2021 | $21,000 | -65.6% | 5,199 | -80.4% | 0.00% | – |
| Q4 2020 | $61,000 | +103.3% | 26,521 | +410.1% | 0.00% | – |
| Q3 2020 | $30,000 | -42.3% | 5,199 | -26.4% | 0.00% | – |
| Q2 2020 | $52,000 | +1200.0% | 7,062 | +229.2% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 2,145 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 2,145 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -58.3% | 2,145 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -29.4% | 2,145 | 0.0% | 0.00% | – |
| Q2 2018 | $17,000 | +13.3% | 2,145 | 0.0% | 0.00% | – |
| Q1 2018 | $15,000 | +36.4% | 2,145 | +95.4% | 0.00% | – |
| Q4 2017 | $11,000 | +10.0% | 1,098 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -9.1% | 1,098 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | – | 1,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,490,534 | $2,772 | 13.66% |
| Madison Avenue Partners, LP | 2,721,051 | $5,061,155 | 0.90% |
| Rubric Capital Management LP | 6,828,065 | $12,700,201 | 0.55% |
| BVF INC/IL | 6,851,051 | $12,742,955 | 0.54% |
| CHI Advisors LLC | 864,822 | $1,608,569 | 0.43% |
| EcoR1 Capital, LLC | 6,117,400 | $11,378,364 | 0.35% |
| Artal Group S.A. | 2,500,000 | $4,650 | 0.26% |
| Tejara Capital Ltd | 107,491 | $199,933 | 0.12% |
| Oasis Management Co Ltd. | 270,000 | $502,200 | 0.10% |
| DCF Advisers, LLC | 70,264 | $130,691 | 0.09% |